Nigeria's Federal Ministry of Health has approved the inclusion of misoprostol on the Essential Drug List (EDL). Misoprostol is used for the prevention and treatment of postpartum hemorrhage, a leading cause of maternal mortality. Its inclusion on the EDL, which gives the drug the status of national priority, follows a MacArthur-supported research report on community-based use of the drug conducted by Dr. Clara Ejembi at Ahmadu Bello University in Zaria.
The privacy of your data is important to us. We've updated our privacy policies in response to General Data Protection Regulation.